Swiss Parenterals Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Swiss Parenterals Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Swiss Parenterals

Based on:

DeciZen not available for IPO

10 Year X-Ray of Swiss Parenterals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25TTM
ROCE % 21.4%18.6%9.3%16.1%27.4%57.8%42.4%49%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 40.74748.448.356.722329136257
Sales YoY Gr.-15.7%2.8%-0.1%17.4%293.9%30.4%24.1%-
Adj EPS 86.11.23.38.775.4104151.38.8
YoY Gr.--23.9%-80.7%180.3%164.3%769.1%38%45.5%-
BVPS (₹) 26.331.933.1044.9369.1328.648145.6
Adj Net
Profit
3.83.40.72.46.455.65884.56
Cash Flow from Ops. 2.87.73.96.13.614.510791-
Debt/CF from Ops. 6.51.94.504.20.70.20-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA49.5%85.5%24.1%
Adj EPS NA164.5%159.4%45.5%
BVPSNA70.8%120.4%46.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25TTM
Return on
Equity %
28.621.83.610.621.136.325.537.43.3
Op. Profit
Mgn %
17.315.11417.924.534.727.530.8NAN
Net Profit
Mgn %
9.37.21.4511.324.919.923.411.4
Debt to
Equity
1.60.8100.500.10-
Working Cap
Days
016218196991822262510
Cash Conv.
Cycle
0154552544457570

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Swiss Parenterals Ltd.

Standalone Consolidated
TTM EPS (₹) 8.8 -
TTM Sales (₹ Cr.) 56.7 -
BVPS (₹.) 45.6 -
Reserves (₹ Cr.) 26 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 7.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Swiss Parenterals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Swiss Parenterals - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Swiss Parenterals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25
Sales40.6647.0348.3548.2956.69223.32291.29361.58
Operating Expenses 33.6540.1241.5939.6442.82145.82212.24250.23
Manufacturing Costs9.1810.9411.859.8413.5515.1130.5724.48
Material Costs19.5123.4122.3120.5419.2492.56116162.01
Employee Cost 1.292.132.812.983.969.6624.5724.24
Other Costs 3.673.634.616.286.0728.4941.1039.50
Operating Profit 7.016.916.768.6513.8777.5079.05111.35
Operating Profit Margin (%) 17.2%14.7%14.0%17.9%24.5%34.7%27.1%30.8%
Other Income 0.210.340.330.680.7111.8727.5410.18
Interest 0.701.112.071.691.190.980.240.22
Depreciation 0.601.273.923.583.117.793.595.62
Exceptional Items -0.16-0.150-0-0000
Profit Before Tax 5.774.721.114.0610.2880.59102.76115.69
Tax 2.041.580.391.433.8121.5032.8230.55
Profit After Tax 3.723.150.722.636.4659.0969.9485.14
PAT Margin (%) 9.2%6.7%1.5%5.4%11.4%26.5%24.0%23.5%
Adjusted EPS (₹)7.85.71.30.08.880.2125.3152.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 12.4717.7718.4527.0733.59272.08183.42268.37
Share Capital 1.061.241.241.647.377.375.585.58
Reserves 11.4216.5317.2125.4326.21264.71177.84262.79
Minority Interest00000000
Debt16.1914.7917.478.2115.379.9620.011.36
Long Term Debt12.5410.3811.295.896.15000
Short Term Debt3.654.416.182.329.229.9620.011.36
Trade Payables9.4210.8311.948.8310.5915.6634.8542.48
Others Liabilities 9.224.0711.136.018.0341.7987.4192.37
Total Liabilities 47.3147.4658.9850.1267.57339.49325.69404.58

Fixed Assets

Gross Block9.1630.4832.9433.5234.4754.6670.5379.42
Accumulated Depreciation3.985.119.0812.6315.547.8811.4216.47
Net Fixed Assets 5.1825.3723.8620.8918.9246.7859.1162.95
CWIP 14.850.260.1804.211.810.2111.71
Investments 0000025.3855
Inventories11.037.749.957.498.7623.2136.1728.95
Trade Receivables6.436.3514.989.9119.0949.2781.1389.03
Cash Equivalents 2.331.944.214.897.1379.2066.3622.90
Others Assets 7.495.805.806.949.46113.8477.71184.04
Total Assets 47.3147.4658.9850.1267.57339.49325.69404.58

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 2.837.683.906.103.6314.48107.1291.02
PBT 5.774.721.114.0610.2880.59102.76115.69
Adjustment 1.232.325.984.994.021.86-19.020.01
Changes in Working Capital -2.121.74-2.43-1.22-6.61-43.8754.65-3.14
Tax Paid -2.06-1.10-0.76-1.73-4.06-24.11-31.27-21.54
Cash Flow From Investing Activity -12.43-6.93-2.24-0.48-7.37-9.1932.13-68.51
Capex -13.10-6.87-2.39-0.74-5.01-2.57-14.31-22.41
Net Investments 00000-12.8336.9347.91
Others 0.67-0.060.150.27-2.366.229.51-94.01
Cash Flow From Financing Activity 10.74-1.150.61-4.955.9710.07-148.87-19.04
Net Proceeds from Shares 1.441.36060000
Net Proceeds from Borrowing 8.74-2.160.91-5.400.27000
Interest Paid -0.70-1.11-2.07-1.69-1.19-0.22-0.24-0.15
Dividend Paid 000000-55.820
Others 1.260.751.77-3.866.9010.29-92.81-18.89
Net Cash Flow 1.14-0.392.270.682.2315.37-9.623.47

Finance Ratio

PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'23Mar'24Mar'25
Ratios
ROE (%)33.1721.713.9911.5421.4843.4430.7137.69
ROCE (%)21.3818.559.2616.127.3657.8442.4348.99
Asset Turnover Ratio0.881.040.960.921.021.320.880.99
PAT to CFO Conversion(x)0.762.445.422.320.560.251.531.07
Working Capital Days
Receivable Days5647769088818286
Inventory Days9670636350383733
Payable Days176158186185184317987

Swiss Parenterals Ltd Stock News

Swiss Parenterals Ltd FAQs

The current trading price of Swiss Parenterals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Swiss Parenterals stood at ₹0.00.
The latest P/E ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.
The 52-week high of Swiss Parenterals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swiss Parenterals is ₹56.69 ( Cr.) .

About Swiss Parenterals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×